Merck & Company Inc is a drug manufacturers-general business based in the US. Merck-and-Company shares (MRK.US) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $106.34 – a decrease of 0.37% over the previous day. Merck-and-Company employs 67,000 staff and has a market cap (total outstanding shares value) of $270.8 billion.
Finder Award
Interactive Brokers
Only you can make the decision on the time to leap. The gauge below shows real-time ratings that are based on 26 popular indicators such as moving averages, for specific time periods. It's not a recommendation but is simply technical analysis that can form part of your research.
Finder might not agree with the analysis and we take no responsibility. We also give no representations or warranty on the accuracy or completeness of the information provided on this page.
Note: The dollar amounts in the table below are in Canadian dollars.
Valuing Merck-and-Company stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Merck-and-Company's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
| Revenue TTM | $58.3 billion |
|---|---|
| Operating margin TTM | 14.87% |
| Gross profit TTM | $42.1 billion |
| Return on assets TTM | 5.12% |
| Return on equity TTM | 7.61% |
| Profit margin | 5.34% |
| Book value | $15.24 |
| Market capitalisation | $270.8 billion |
TTM: trailing 12 months
Dividend payout ratio: 103.91% of net profits
Recently Merck-and-Company has paid out, on average, around 103.91% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.72% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Merck-and-Company shareholders could enjoy a 2.72% return on their shares, in the form of dividend payments. In Merck-and-Company's case, that would currently equate to about $2.84 per share.
Merck-and-Company's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
Merck-and-Company's most recent dividend payout was on 6 October 2023. The latest dividend was paid out to all shareholders who bought their shares by 14 September 2023 (the "ex-dividend date").
Merck-and-Company's shares were split on a 1048:1000 basis on 3 June 2021. So if you had owned 1000 shares the day before before the split, the next day you'd have owned 1048 shares. This wouldn't directly have changed the overall worth of your Merck-and-Company shares – just the quantity. However, indirectly, the new 4.6% lower share price could have impacted the market appetite for Merck-and-Company shares which in turn could have impacted Merck-and-Company's share price.
Merck & Co. , Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. The company serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers.
Your guide to how ETFs work and whether this type of investment is right for you.
Read more…
Learning how to read stock charts and recognize chart patterns can unlock your success as a trader.
Read more…
Owning a stock means you own part of a company and can potentially grow your wealth. But there is a risk of loss.
Read more…Steps to owning and managing Yoshitsu Co. stocks, with 24-hour and historical pricing before you buy.
Steps to owning and managing Cerberus Cyber Sentinel stocks, with 24-hour and historical pricing before you buy.
Steps to owning and managing Fresh Vine Wine, Inc stocks, with 24-hour and historical pricing before you buy.
Steps to owning and managing DGX with 24-hour and historical pricing before you buy.
Everything we know about the Nuvectis Pharma IPO plus information on how to buy in.
Steps to owning and managing BuzzFeed, Inc stocks, with 24-hour and historical pricing before you buy.
These are the best renewable energy stocks to buy now in Canada.
Steps to owning and managing ADMA with 24-hour and historical pricing before you buy.
Steps to owning and managing DY with 24-hour and historical pricing before you buy.
Steps to owning and managing VICI with 24-hour and historical pricing before you buy.
